LimFlow
Latest round
- Series D
Last raised
- Mar 2022
Total raised
- $106M
Investors
- 6
About LimFlow
LimFlow SA, established in 2012 in Paris, France, focuses on developing medical technologies for vascular treatment. The company was founded by Martin Rothman, who has a history of entrepreneurial endeavors in the medical field. Inari Medical, Inc.000 mn, with the deal finalized on November 1, 2023, allowing for additional payments upon achieving certain milestones.LimFlow specializes in innovative medical solutions aimed at addressing critical needs in the treatment of vascular diseases. Their core product offering is centered around a proprietary catheter-based system designed to restore blood flow in patients with end-stage peripheral artery disease (PAD), specifically targeting individuals who have not responded to conventional therapies. This system facilitates a minimally invasive procedure that enables healthcare providers to establish a new pathway for blood flow without the need for major surgery. LimFlow's products serve hospitals and healthcare facilities, primarily focusing on markets in North America and Europe, where the demand for advanced treatment options for PAD is growing.9. The company's revenue model is structured around the sale of its catheter systems and associated medical devices to healthcare providers, including hospitals and specialty clinics. Transactions are based on a direct-to-business sales model, where healthcare facilities purchase devices based on patient needs and treatment protocols., LimFlow aims to leverage its innovative technology to expand patient access to life-saving treatments for chronic limb-threatening ischemia. The strategic acquisition supports Inari Medical’s goal of addressing critical unmet medical needs, thus establishing a broader geographical presence and enhancing service capabilities in the vascular treatment sector.
Who invested in LimFlow
6 investors across 7 rounds
See all investors in LimFlow
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Mar 31, 2022
Amount
$39M
Investors
Series C
Mar 15, 2022
Amount
$2.2M
Investors
Series C
Aug 18, 2021
Amount
$4.7M
Investors
Series C
Dec 12, 2019
Amount
$17M
Investors
Series C
Jun 1, 2018
Amount
$21M
Investors
Series B
Dec 18, 2017
Amount
$4.7M
Investors
Series A
Aug 15, 2014
Amount
$17M
Investors
Questions about LimFlow
Who invested in LimFlow?
LimFlow has 6 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LimFlow raised?
LimFlow has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did LimFlow last raise money?
LimFlow's most recent round on record is a Series D, in Mar 2022.
What does LimFlow do?
LimFlow SA, established in 2012 in Paris, France, focuses on developing medical technologies for vascular treatment.
Where is LimFlow headquartered?
LimFlow is headquartered in Paris, France.
Which VCs invest in companies like LimFlow?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at LimFlow's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like LimFlow? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.